Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. [electronic resource]
Producer: 20200921Description: 179-188 p. digitalISSN:- 1573-7241
- Aged
- Clopidogrel -- adverse effects
- Coronary Artery Disease -- diagnostic imaging
- Coronary Thrombosis -- mortality
- Cytochrome P-450 CYP2C19 -- genetics
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Percutaneous Coronary Intervention -- adverse effects
- Pharmacogenomic Variants
- Platelet Aggregation Inhibitors -- adverse effects
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Registries
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Stents
- Ticagrelor -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.